These tumor-specific Th1 cells, armed with the ability to produce IFN-γ and IL-2, subsequently traffic back to the tumor, where they significantly enhance the activity of tumor-infiltrating cytotoxic CD8+ T cells, contributing to tumor cell lysis and control [16]. Here, CD8A is linked to neoplasm.